Debt-to-equity in % of GeneDx Holdings Corp. from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GeneDx Holdings Corp. quarterly Debt-to-equity history and change rate from Q2 2021 to Q3 2025.
  • GeneDx Holdings Corp. Debt-to-equity for the quarter ending 30 Sep 2025 was 70.1 %, a 24.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GeneDx Holdings Corp. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 70.1 -23.1 -24.8% 30 Sep 2025
Q2 2025 76.6 -6.69 -8.03% 30 Jun 2025
Q1 2025 84.6 +11.4 +15.6% 31 Mar 2025
Q4 2024 89.4 +21.6 +31.8% 31 Dec 2024
Q3 2024 93.2 +22.8 +32.4% 30 Sep 2024
Q2 2024 83.3 +20.7 +33% 30 Jun 2024
Q1 2024 73.2 +16 +28.1% 31 Mar 2024
Q4 2023 67.8 +12.3 +22.2% 31 Dec 2023
Q3 2023 70.4 +22.5 +47% 30 Sep 2023
Q2 2023 62.7 +13.3 +26.8% 30 Jun 2023
Q1 2023 57.2 -123 -68.2% 31 Mar 2023
Q4 2022 55.5 +441 31 Dec 2022
Q3 2022 47.9 +172 30 Sep 2022
Q2 2022 49.4 +116 30 Jun 2022
Q1 2022 180 31 Mar 2022
Q4 2021 -386 31 Dec 2021
Q3 2021 -124 30 Sep 2021
Q2 2021 -66.4 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.